COMBINATORX CRXX (NASDAQ) $ 0.60 Change: +0.05 +8.33% | Volume: 29,233
Sponsored by Click here!
Headlines on CRXX

Synavive data sends CombinatoRx to all-time lows

(NEW YORK)Shares of CombinatoRx Inc. crashed to an all-time low Monday after the biotech company said its lead drug candidate missed its main goal in clinical trial.READ MORE
Oct 06, 2008 8:17PM
Keywords: CRXX

CombinatoRx plunges on Synavive trial failure

(CAMBRIDGE, Mass.)The drug candidate Synavive missed its main goal in a clinical trial, developer CombinatoRx Inc. said Monday, as the drug did not significantly improve symptoms of osteoarthritis o...READ MORE
Oct 06, 2008 10:04AM
Keywords: CRXX

CombinatoRx 2Q loss grows on higher research costs

(CAMBRIDGE, Mass.)Biotech drug developer CombinatoRx Inc. said Wednesday its second-quarter loss widened as the company spent more money to develop its drug candidates Synavive and CRx-401 and reven...READ MORE
Aug 06, 2008 10:33AM
Keywords: CRXX, ANPI


Data Provided By Barchart.com
advertisement